stockportfolio.pro
MTD vs RMD: Which Stock Is the Better Buy?
Mettler-Toledo International Inc. and ResMed Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — MTD vs RMD, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Mettler-Toledo International Inc. (MTD) | ResMed Inc. (RMD) | |
|---|---|---|
| Market cap | $26.4B | $30.4B |
| Revenue (latest FY) | $4.03B | $5.15B |
| Net income (latest FY) | $869.19M | $1.40B |
| Revenue growth (5y CAGR) | 5.5% | 11.7% |
| Net margin | 21.6% | 27.2% |
| Return on equity | -3677.4% | 23.5% |
| P/E ratio | 30.8 | 20.2 |
| Dividend yield | — | 1.1% |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
See the full MTD vs RMD breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open MTD's full financials → Open RMD's full financials →More comparisons
Frequently asked questions
Which is bigger, MTD or RMD?
ResMed Inc. is larger by market capitalization — $30.4B versus $26.4B.
Which grows faster, MTD or RMD?
Over the last five fiscal years, ResMed Inc. grew revenue faster — 11.7%/yr versus 5.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.